Keyphrases
MicroRNA
100%
Diabetic Kidney Disease
50%
Renal Fibrosis
50%
Renal Disease
25%
Transforming Growth Factor-β Signaling
15%
MiR-192
10%
MiR-200
10%
MiR-433
10%
Experimental Animal Studies
10%
MiR-29a
10%
Transforming Growth Factor-β
10%
Kidney
10%
MicroRNA-21 (miR-21)
10%
Chronic Kidney Disease
10%
Therapeutic Potential
9%
Kidney Disease
5%
Post-transcriptional Repression
5%
Renal Development
5%
Normal Renal Function
5%
Pathological Role
5%
Development Functions
5%
Kidney Disease Progression
5%
Early Biomarker
5%
Homeostasis
5%
Epithelial-to-mesenchymal Transition
5%
Disease Targets
5%
Extracellular Matrix Protein 1 (ECM1)
5%
Early Treatment
5%
Physiological Function
5%
Gene Expression
5%
Early Diagnosis
5%
Target mRNA
5%
Extracellular Matrix
5%
MicroRNA Expression
5%
Non-coding RNA (ncRNA)
5%
Cellular Processes
5%
Immunology and Microbiology
Experimental Animal
70%
Gene Expression
60%
Transforming Growth Factor Beta
50%
Blood Plasma
50%
Kidney Transplantation
50%
Cell Culture
50%
Animal Experiment
20%
Extracellular Matrix
20%
Kidney Development
10%
Homeostasis
10%
Kidney Function
10%
Matrix Protein
10%
Mediator
10%
Epithelial Mesenchymal Transition
10%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Diabetic Nephropathy
50%
Kidney Fibrosis
50%
Kidney Disease
31%
Transforming Growth Factor Beta
22%
Biological Marker
14%
Experimental Animal
14%
microRNA 200
9%
microRNA 192
9%
microRNA 29
9%
Chronic Kidney Failure
9%
Cell Culture
5%
Replacement Therapy
5%
Kidney Injury
5%